English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Results: In each monthly measurement, in the BRVO group, foveal thickness decreased from baseline statistically significantly from baseline (p<0.05) and ETDRS score of visual acuity increase also was statistically significant (p<0.05) at each interval. In the CVRO group, although 1 month after injection, foveal thickness decreased significantly (p<0.05), and second and third months, the reduction in foveal thickness was not statistically significant (p>0.05) and compared with preinjection values, increase ETDRS score at all months was not statistically significant (p>0.05).

Short term results after single dose intravitreal bevacizumab treatment for macular edema secondary to central and branch retinal vein occlusions